MHRA Updates Botulinum Toxin Warnings: Medico-Legal Implications for Aesthetic Practitioners

In July 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) issued updated safety advice regarding botulinum toxin type A following reports of iatrogenic botulism after therapeutic and cosmetic use. In this blog, we explore the update from a medical-legal perspective.